Cardioprotective Strategies to Prevent Cancer Treatment-Related Cardiovascular Toxicity: a Review

被引:0
作者
Jenica N. Upshaw
机构
[1] Tufts Medical Center,Division of Cardiology
来源
Current Oncology Reports | 2020年 / 22卷
关键词
Cardio-oncology; Heart failure; Chemotherapy; Anthracyclines; Radiation; Cardiovascular disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 1319 条
[1]  
Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34
[2]  
Miller KD(2016)Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States Cancer Epidemiol Biomark Prev 25 1029-1036
[3]  
Jemal A(2019)Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases Lancet. 394 1041-1054
[4]  
Bluethmann SM(2013)Modifiable risk factors and major cardiac events among adult survivors of childhood cancer J Clin Oncol Off J Am Soc Clin Oncol 31 3673-3680
[5]  
Mariotto AB(2019)Heart disease and stroke statistics-2019 update: a report from the American Heart Association Circulation. 139 e56-e528
[6]  
Rowland JH(2012)Identification of the molecular basis of doxorubicin-induced cardiotoxicity Nat Med 18 1639-1642
[7]  
Strongman H(2017)Detailed echocardiographic phenotyping in breast cancer patients: associations with ejection fraction decline, recovery, and heart failure symptoms over 3 years of follow-up Circulation. 135 1397-1412
[8]  
Gadd S(2017)Arginine-nitric oxide metabolites and cardiac dysfunction in patients with breast cancer J Am Coll Cardiol 70 152-162
[9]  
Matthews A(2003)Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer. 97 2869-2879
[10]  
Mansfield KE(2016)Noninvasive measures of ventricular-arterial coupling and circumferential strain predict cancer therapeutics-related cardiac dysfunction J Am Coll Cardiol Img 9 1131-1141